Andhra HC holds ruling in Ranbaxy-Sun Pharma case

Tags: News
The Andhra Pradesh High Court will announce its decision on Saturday on the plea of two investors requesting it to restrain BSE and NSE from giving any clearance to the $3.2 billion Sun Pharma-Ranbaxy merger.

After hearing the case, following the Supreme Court’s direction on Wednesday, the court reserved the order for Saturday. The court had earlier issued interim orders to maintain status quo with regard to the merger.

The petitioners at the end of April had raised objections over the heavy trading of Ranbaxy share before the announcement of acquisition of Ranbaxy by Sun Pharma. The court had also asked other parties like Daichii Sankyo and Silver Street developers not to go ahead with the process.

Justice G Chandraiah heard arguments on behalf of petitioners as well as Sun Pharma, Ranbaxy and Sebi. The market regulator informed the court that an investigation was on regarding insider trading as Ranbaxy shares jumped over 20 per cent, a week before the deal was announced.

The Ranbaxy counsel said merger should not be stopped, as insider trading and merger were two different things and could not be looked from the same angle. “The petitioners have no locus standi to file the petition to restrain the merger citing insider trading as they bought shares after the announcement," said D Prakash Reddy, counsel for Ranbaxy.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Copy the characters (respecting upper/lower case) from the image.

EDITORIAL OF THE DAY

  • India needs to think quick and act fast to crank up its crude reserves

    With China overtaking the US in crude oil imports in April with imports at 7.4 million barrels per day, its thirst for building reserves and proving i

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

TODAY'S COLUMNS

Arun Kumar Jain

Politics has to be about problem solving

One of the most common sights every morning at major ...

Kuruvilla Pandikattu SJ

Start meditating to preserve grey matter

Since 1970, life expectancy around the world has risen dramatically, ...

Gautam Gupta

It’s ethnic wear all the way in Indian fashion

India is one of the most diverse countries in the ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture